2019
DOI: 10.1016/j.ajog.2019.06.025
|View full text |Cite
|
Sign up to set email alerts
|

A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
77
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 81 publications
(81 citation statements)
references
References 31 publications
3
77
1
Order By: Relevance
“…The area under the receiver operating characteristic curve in predicting SMM using the risk stratification approach was 68% in the current study. In the United States, the areas under the curve in studies that used comorbidity index to predict SMMwere 78% [56], 65% [60], and 70% [65]. These were similar to that of the current study.…”
Section: Plos Onesupporting
confidence: 86%
“…The area under the receiver operating characteristic curve in predicting SMM using the risk stratification approach was 68% in the current study. In the United States, the areas under the curve in studies that used comorbidity index to predict SMMwere 78% [56], 65% [60], and 70% [65]. These were similar to that of the current study.…”
Section: Plos Onesupporting
confidence: 86%
“…Despite the low sensitivity of the maternal comorbidity index to predict SMM, the c-statistic of the maternal comorbidity index was similar to the original study that developed the index (area under the curve = 0.66) 12 and the validation study (area under the curve = 0.67). 14 In addition, clinical use for the index is promising and has been validated in a prospective clinical study (c-statistic = 0.83) 13,15 ; however, the clinical study modified the comorbidity index to include conditions that have been shown to be associated with SMM, such as prepregnancy obesity and morbidly adherent placenta. The authors of the current study also agree that the maternal comorbidity index score needs to be modified to include these other comorbid conditions, including individual-level social risk factors and hospital-level factors to appropriately flag women that are at high risk for adverse birth outcomes, when used in a clinical setting.…”
Section: Discussionmentioning
confidence: 99%
“…It can also be used to track patients’ burden of comorbidities across practitioners, institutions, and geographic level . The maternal comorbidity index has been validated in multiple studies, including one study conducted in a hospital in Alberta, Canada, and one study conducted in a single, tertiary‐care, academic hospital in the United States, both using clinical data linked to hospital administrative data; however, both noted that the generalizability of the index was unknown and needed to be examined. In addition, a national study examined the association between maternal comorbidity index and SMM using hospital administrative data, but they limited their sample to only low‐delivery‐volume (<1000) hospitals .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of epidural analgesia for labor in the United States was 73.1% in 2015, and as high as 86% at an academic tertiary center. (3,4) Epidural analgesia has been deployed in Vietnam in the past decade, but the technique is not uniformly covered by Vietnamese health insurance and many women remain unaware of this option.…”
Section: Introductionmentioning
confidence: 99%